Christopherr Fenimore News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-three brokerages that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and eighteen have issued a buy recommendation on the […]

Assenagon Asset Management S.A. raised its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 129.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 216,523 shares of the biopharmaceutical company’s stock after buying an additional 122,103 shares during the period. Regeneron […]

Meyer Handelman Co. grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,265 shares of the biopharmaceutical company’s stock after acquiring an additional 30 shares during the quarter. Meyer Handelman Co.’s holdings […]

Meyer Handelman Co. grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,265 shares of the biopharmaceutical company’s stock after acquiring an additional 30 shares during the quarter. Meyer Handelman Co.’s holdings […]

GPS Wealth Strategies Group LLC grew its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 15.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 513 shares of the biopharmaceutical company’s stock after purchasing an additional 70 shares during the quarter. […]